Article
Dysregulation of TET2 in hematologic malignancies.
International journal of hematology - 1 Jan 2017
Chiba Shigeru
Abstract excerpt
The TET dioxygenases, TET1, TET2, and TET3, catalyze transfer of an oxygen atom to the methyl group of 5-methylcytocine (5-mC), converting it to 5-hydroxymethylcytocine (5-hmC). Among the genes encoding these enzymes, ten-eleven translocation 2 (TET2) is frequently mutated somatically in both myeloid and lymphoid malignancies. Because these TET2 mutations result in the impairment of the dioxygenase activity of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
